Akari Therapeutics PLC (AKTX) — Cash Flow Quality Index

Latest as of March 2023: -4.88x

Akari Therapeutics PLC (AKTX) has a Cash Flow Quality Index of -4.88x as of March 2023. Operating cash flow of $-4.88 Million is below net income of $1.00 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore AKTX cash flow conversion to assess how effectively this company generates cash.

Cash Flow Quality Index

-4.88x
Operating CF / Net Income

Operating Cash Flow

$-4.88 Million
USD

Net Income

$1.00 Million
USD

Data as of

Mar 2023
Most recent filing

Annual Cash Flow Quality Index for Akari Therapeutics PLC (None–None)

Year-by-year earnings quality comparison for Akari Therapeutics PLC. For live market cap and the full company financial profile, see Akari Therapeutics PLC market cap and net worth.

Year Quality Index Operating CF (USD) Net Income YoY Change
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.